Written By
Wendy Ketner, M.D.
Edited By
Dani Alexis Ryskamp, J.D.
Updated on February 29, 2024
Medically Reviewed
Litigation Guides
Exposure to PFAS-containing firefighting foam is now linked to cancer. This guide examines the connection and the existing litigation on the subject.
Written By
Wendy Ketner, M.D.
Medically Reviewed
Per- and polyfluoroalkyl substances (PFAS) is a class of compounds that includes two industrial solvents: perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). PFAS chemicals have been used in consumer products worldwide since the 1950s.
Because the carbon-fluoride bond in the chemicals is among the strongest chemical bonds in nature, these chemicals do not break down in the environment. They are thus among the substances known as “forever chemicals.”1
PFAS chemicals appear in:
“How does PFAS cause cancer?” remains a question under investigation. One exploratory study of PFOA and breast cancer, however, suggests that exposure to the chemical may increase the levels of certain cellular messengers while decreasing the levels of compounds that protect cells from becoming cancerous.4
In particular, the study focuses on how PFAS chemicals interact with hormone-sensitive cells. Further study may help to explain PFAS chemicals’ effects on other hormone-sensitive cells, such as those in the testicles, liver, and pancreas.
Studies of PFAS have found the substances to be “linked to many harmful health effects, including cancer,” and thus to rank as a “serious global health threat.”2
Medical studies of PFAS chemicals indicate that exposure to one or more chemicals in the class is connected to an increased risk of cancer. A medical panel convened in a PFOA-related class-action lawsuit determined that the most likely outcomes of PFOA exposure included:
These findings are consistent with multiple independent medical studies connecting PFOA exposure to the listed medical conditions.
We help attorneys access the latest legal research, medical record reviews, physician consultations, and world-class experts.
AFFFs are used to fight liquid fuel fires. They work by forming a barrier over the liquid fuel, containing flammable vapors to prevent the spread of the fire and extinguish it.7
The US Fire Administration (USFA) states that while foams that contain PFAS are more effective at extinguishing liquid-fuel fires, they are also linked to “harmful effects on humans and animals” and do not degrade in the environment.
In January 2023, the Department of Defense issued new guidelines for firefighting foams used on military bases. These foams must effectively fight liquid-fuel fires without containing PFAS chemicals.8
Firefighting is associated with higher risks of several types of cancer, as well as higher cancer risks from non-PFAS sources like smoke.6
Determining whether exposure to AFFFs is the primary cause of a firefighter’s cancer requires careful attention on a case-by-case basis and poses an ongoing medical-legal challenge.
PFAS chemicals have various uses. One is as an ingredient in aqueous film-forming foams (AFFFs), which are used in firefighting. Because firefighters come into contact with PFAS as part of their job, they may face higher risks of forming PFAS-related cancers than members of the general population.
The risk is heightened by the fact that many firefighters aren’t aware of the potentially dangerous outcomes of AFFFs exposure. One study found that over 80 percent of surveyed Florida fire departments used AFFFs - and that most of the firefighters surveyed did not know PFAS chemicals are linked to cancer.5
In one study of female firefighters in San Francisco, researchers found elevated carcinogen levels in the firefighters’ blood samples - an early warning sign of a heightened risk of developing future cancers.6
As awareness of PFAS and its effects expands, so do lawsuits and legislative actions intended to address PFAS contamination and exposure.
Legislative steps related to PFAS include:
1.
National Institute of Environmental Health Sciences. Perfluoroakyl and polyfluoroalkyl substances (PFAS). https://www.niehs.nih.gov/health/topics/agents/pfc
2.
Pelch, K. E., Reade, A., Wolffe, T. A. M., & Kwiatkowski, C. F. (2019). PFAS health effects database: Protocol for a systematic evidence map. In Environment International. https://doi.org/10.1016/j.envint.2019.05.045
3.
Nicole, W. (2013). PFOA and cancer in a highly exposed community: New findings from the C8 science panel. In Environmental Health Perspectives. https://doi.org/10.1289/ehp.121-A340
4.
Pierozan, P., Jerneren, F., & Karlsson, O. (2018). Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells. Archives of Toxicology. https://doi.org/10.1007/s00204-018-2181-4
5.
Caban-Martinez, A. J., Solle, N. S., Feliciano, P. L., Griffin, K., Santiago, K. M., Lee, D. J., Daunert, S., Deo, S. K., Fent, K., Calkins, M., Burgess, J. L., & Kobetz, E. N. (2019). Aqueous Film-Forming Foams and Knowledge of Perfluorinated Compounds among Florida Firefighters. In Journal of Occupational and Environmental Medicine. https://doi.org/10.1097/JOM.0000000000001566
6.
Trowbridge, J., Gerona, R. R., Lin, T., Rudel, R. A., Bessonneau, V., Buren, H., & Morello-Frosch, R. (2020). Exposure to Perfluoroalkyl Substances in a Cohort of Women Firefighters and Office Workers in San Francisco. Environmental Science and Technology. https://doi.org/10.1021/acs.est.9b05490
7.
US Fire Administration. Firefighting foams: PFAS vs fluorine-free foams. https://www.usfa.fema.gov/blog/firefighting-foams-pfas-vs-fluorine-free-foams/
8.
Department of Defense. Performance specification: fire extinguishing agent, fluorine-free foam (F3) liquid concentrate, for land-based, fresh water applications. https://media.defense.gov/2023/Jan/12/2003144157/-1/-1/1/MILITARY-SPECIFICATION-FOR-FIRE-EXTINGUISHING-AGENT-FLUORINE-FREE-FOAM-F3-LIQUID-CONCENTRATE-FOR-LAND-BASED-FRESH-WATER-APPLICATIONS.PDF
9.
Napoli Shkolnik files complaint on behalf of the City of Wausau, Wisconsin against fifteen PFAS manufacturers and sixty-one major players in the insurance industry. https://www.wausauwi.gov/home/showpublisheddocument/10300/638370262392870000
10.
Mentzer R. PFSA lawsuits involve complex science and law, but settlements can be worth millions. https://www.wpr.org/environment/pfas-lawsuits-involve-complex-science-and-law-settlements-can-be-worth-millions
11.
Scully M and Ledger B. PFAS settlements: future of PFAS litigation landscape to be determined by upcoming decision. Reuters, August 31, 2023. https://www.reuters.com/legal/legalindustry/pfas-settlements-future-pfas-litigation-landscape-be-determined-by-upcoming-2023-08-31/
12.
Hardin T. 3M agrees to $10.3 billion settlement in PFAS-related lawsuits. DC Report. https://www.dcreport.org/2023/06/25/3m-agrees-to-10-3-billion-settlement-in-pfas-related-lawsuits/
13.
United States District Court for the District of South Carolina. Aqueous film-forming foams (AFFF) products liability litigation MDL No. 2873. https://www.scd.uscourts.gov/mdl-2873/current.asp
14.
US Environmental Protection Agency. Changes to TRI reporting requirements for per- and polyfluoroalkyl substances and to supplier notifications for chemicals of special concern. https://www.epa.gov/toxics-release-inventory-tri-program/changes-tri-reporting-requirements-and-polyfluoroalkyl
15.
US Environmental Protection Agency. Proposed designation of perfluorooctanoic acid (PFOA) and perfluorooctainesulfonic acid (PFOS) as CERCLA hazardous substances. https://www.epa.gov/superfund/proposed-designation-perfluorooctanoic-acid-pfoa-and-perfluorooctanesulfonic-acid-pfos
16.
United States Environmental Protection Agency. EPA announces proposed decision to regulate PFOA and PFOS in drinking water. February 20, 2020. https://www.epa.gov/newsreleases/epa-announces-proposed-decision-regulate-pfoa-and-pfos-drinking-water
About the author
Wendy Ketner, M.D.
Dr. Wendy Ketner is a distinguished medical professional with a comprehensive background in surgery and medical research. Currently serving as the Senior Vice President of Medical Affairs at the Expert Institute, she plays a pivotal role in overseeing the organization's most important client relationships. Dr. Ketner's extensive surgical training was completed at Mount Sinai Beth Israel, where she gained hands-on experience in various general surgery procedures, including hernia repairs, cholecystectomies, appendectomies, mastectomies for breast cancer, breast reconstruction, surgical oncology, vascular surgery, and colorectal surgery. She also provided care in the surgical intensive care unit.
Her research interests have focused on post-mastectomy reconstruction and the surgical treatment of gastric cancer, including co-authoring a textbook chapter on the subject. Additionally, she has contributed to research on the percutaneous delivery of stem cells following myocardial infarction.
Dr. Ketner's educational background includes a Bachelor's degree from Yale University in Latin American Studies and a Doctor of Medicine (M.D.) from SUNY Downstate College of Medicine. Moreover, she is a member of the Board of Advisors for Opollo Technologies, a fintech healthcare AI company, contributing her medical expertise to enhance healthcare technology solutions. Her role at Expert Institute involves leveraging her medical knowledge to provide insights into legal cases, underscoring her unique blend of medical and legal acumen.
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.
We're here to help you build a stronger case. Retain a leading expert witness today.
Need your medical records reviewed? Consult one of our 75+ on-staff physicians who can help evaluate the strengths and weaknesses of your case.